LBX Pharmacy Chain

603883

CNE1000023Q8

Drug Retailers

End-of-day quote Shanghai S.E. Other stock markets 21/01/2026			5-day change	1st Jan Change
15.46 ^CNY	-0.71%		-0.83%	+4.46%

12-11	LBX Pharmacy Chain Joint Stock Company(SHSE:603883) dropped from Shanghai Stock Exchange Health Care Sector Index	CI
28/10/25	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Nanhua Futures CFO Steps Down

Published on 05/15/2024 at 07:59 am BST - Modified on 05/15/2024 at 08:00 am BST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about LBX Pharmacy Chain

12-11	LBX Pharmacy Chain Joint Stock Company(SHSE:603883) dropped from Shanghai Stock Exchange Health Care Sector Index	CI
28/10/25	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
26/08/25	Nomura Adjusts LBX Pharmacy Chain's Price Target to 21.58 Yuan From 29.61 Yuan, Keeps at Buy	MT
25/08/25	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended June 30, 2025	CI
06/05/25	LBX Pharmacy Chain JSC's Controlling Shareholder To Sell Up To 3% Stake In Co	RE
05/05/25	LBX Pharmacy Chain Names President	MT
29/04/25	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
29/04/25	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2024	CI
29/10/24	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
18/10/24	Nomura Adjusts LBX Pharmacy Chain's Price Target to 29.61 Yuan From 34.87 Yuan, Keeps at Buy	MT
04/10/24	LBX Pharmacy Chain's Chairman Released From Detention	MT
29/08/24	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended June 30, 2024	CI
31/07/24	LBX Pharmacy Chain's Chairman Detained Amid Probed; Shares Drop 5%	MT
18/07/24	Nomura Adjusts LBX Pharmacy Chain's Price Target to 34.87 Yuan From 35.52 Yuan, Keeps at Buy	MT
15/05/24	Nanhua Futures CFO Steps Down	MT
29/04/24	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/04/24	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI
07/03/24	Nomura Adjusts LBX Pharmacy Chain’s Price Target to 45.79 Yuan From 43.96 Yuan, Keeps at Buy	MT
31/10/23	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
31/10/23	Nomura Adjusts LBX Pharmacy Chain's Price Target to 43.96 Yuan From 44.28 Yuan, Keeps at Buy	MT
29/10/23	LBX Pharmacy Chain Joint Stock Company agreed to acquire 35% stake in Yangzhou Baixinyuan Pharmaceutical Chain Co., Ltd. from Chen Jinxi for CNY210 million.	CI
30/08/23	LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended June 30, 2023	CI
07/08/23	Nomura Adjusts LBX Pharmacy's Price Target to 44.28 Yuan From 42.20 Yuan, Keeps at Buy	MT
27/07/23	Bank of Qinghai Gets New Majority Shareholder	MT
18/05/23	Nomura Starts LBX Pharmacy Chain at Buy With 42.2 Yuan Price Target	MT

LBX Pharmacy Chain JSC is a China-based company principally engaged in the sale of pharmaceuticals, other health and beauty related products. The Company operates its businesses through three segments. Retail segment is mainly engaged in the business of retailing goods. Wholesale segment is mainly involved in the wholesale business of merchandise. Other Business segment is mainly involved in the pharmaceutical manufacturing and other businesses. The Companyâs main products comprise proprietary Chinese and western medicines, Chinese herbal medicines, health maintenance Chinese medicines, health equipment, health foods, general foods, personal care products and household appliances. The Company mainly conducts its businesses in the domestic market.

Employees

40,132

Sector

Drug Retailers

Calendar

04-22 - Q4 2025 Earnings Release

More about the company